Sarepta Therapeutics said early Tuesday that a patient had died after receiving its gene therapy Elevidys, which treats the ...

A young person with Duchenne muscular dystrophy died following treatment with the recently approved gene therapy ...

WASHINGTON (AP) — Sarepta Therapeutics said Tuesday that a patient died while taking its closely watched gene therapy for muscular dystrophy, sending company shares plummeting more than 25%.

The unidentified patient died in January, a month after getting the transplant at a hospital in Ohio, Lynn Sutfin, a spokesperson for Michigan’s Department of Health and Human Services told The ...